Persistent endotheliopathy in the pathogenesis of long COVID syndrome
Helen Fogarty,Liam Townsend,Hannah Morrin,Azaz Ahmad,Claire Comerford,Ellie Karampini,Hanna Englert,Mary Byrne,Colm Bergin,Jamie M. O’Sullivan,Ignacio Martin‐Loeches,Parthiban Nadarajan,Ciaran Bannan,Patrick W. Mallon,Gerard F. Curley,Roger J.S. Preston,Aisling M. Rehill,Dennis McGonagle,Cliona Ni Cheallaigh,Ross I. Baker,Thomas Renné,Soracha E. Ward,James S. O’Donnell,the Irish COVID‐19 Vasculopathy Study investigators,Niamh O’Connell,Kevin Ryan,Dermot Kenny,Judicael Fazavana,Roger J. S. Preston,
DOI: https://doi.org/10.1111/jth.15490
2021-09-12
Journal of Thrombosis and Haemostasis
Abstract:BackgroundPersistent symptoms including breathlessness, fatigue and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this 'Long COVID' syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID-19. We hypothesized that endothelial cell activation may be sustained in convalescent COVID-19 patients and contribute to Long COVID pathogenesis. Patients and MethodsFifty patients were reviewed at a median of 68 days following SARS-CoV-2 infection. In addition to clinical workup, acute phase markers, EC activation and NETosis parameters and thrombin generation were assessed. ResultsThrombin generation assays revealed significantly shorter lag times (p<0.0001, 95% CI -2.57– -1.02min), increased endogenous thrombin potential (ETP) (p=0.04, 95% CI 15–416nM/min) and peak thrombin (p<0.0001, 95% CI 39–93nM) in convalescent COVID-19 patients. These pro-thrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including VWF:Ag, VWF propeptide (VWFpp) and Factor VIII (FVIII:C) were significantly elevated in convalescent COVID-19 compared to controls (p=0.004, 95% CI 0.09–0.57IU/ml; p=0.009, 95% CI 0.06–0.5IU/ml; p=0.04, 95% CI 0.03–0.44IU/ml, respectively). In addition, plasma soluble thrombomodulin (sTM) levels were significantly elevated in convalescent COVID-19 (p=0.02, 95% CI 0.01–2.7ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6-minute walk tests. ConclusionsCollectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID-19 and raise the intriguing possibility that this may contribute to Long COVID pathogenesis.
peripheral vascular disease,hematology